戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 commodates nevanimibe and an endogenous acyl-coenzyme A.
2 d to be essential for PvrA to bind palmitoyl coenzyme A.
3 ulation of citrate, the precursor for acetyl coenzyme A.
4 is from lysophosphatidic acid (LPA) and acyl-coenzyme A.
5                                     Caffeoyl-coenzyme A 3-O-methyltransferase (CCoAOMT) is an S-adeno
6 s conversion of acetyl coenzyme A to malonyl coenzyme A, a carbon donor for long-chain FA synthesis,
7  human Naa60 (hNaa60) in complex with Acetyl-Coenzyme A (Ac-CoA) or Coenzyme A (CoA).
8 DIP2A) is known to be involved in acetylated coenzyme A (Ac-CoA) synthesis and is primarily expressed
9  the transfer of an acetyl group from acetyl-coenzyme A (Ac-CoA) to the amine of a wide range of subs
10  with inositol hexaphosphate (InsP6), acetyl-coenzyme A (AcCoA) and/or substrate Resistance to Ralsto
11                                       Acetyl-coenzyme A (AcCoA) is a major integrator of the nutritio
12 at catalyzes pyruvate's conversion to acetyl coenzyme A (AcCoA), thereby connecting these two pathway
13 ne residues by employing the cofactor acetyl-coenzyme A (AcCoA), thereby providing a dynamic control
14 gosome biogenesis via its metabolite, acetyl-coenzyme A (AcCoA).
15 ased levels of acetyl phosphate, acetoacetyl coenzyme A (acetoacetyl-CoA), butyryl CoA, acetoacetate,
16 d ferredoxin for glucose oxidation to acetyl coenzyme A (acetyl-CoA) and CO2, NADH for the reduction
17  in conversion of acetyl phosphate to acetyl-coenzyme A (acetyl-CoA) and posttranscriptionally regula
18                  Coenzyme A (CoA) and acetyl-coenzyme A (acetyl-CoA) are ubiquitous cellular molecule
19 Acetate and the related metabolism of acetyl-coenzyme A (acetyl-CoA) confer numerous metabolic functi
20                                       Acetyl coenzyme A (acetyl-CoA) generated from glucose and aceta
21 t can also catalyze the hydrolysis of acetyl-Coenzyme A (acetyl-CoA) in the absence of an arylamine s
22                                       Acetyl coenzyme A (acetyl-CoA) is a key metabolite at the cross
23               Metabolic production of acetyl coenzyme A (acetyl-CoA) is linked to histone acetylation
24 riglycerides, suggesting an increased acetyl coenzyme A (acetyl-CoA) load.
25 tochondrial homeostasis by regulating acetyl-coenzyme A (acetyl-CoA) metabolism.
26 rnative carbon source utilization for acetyl coenzyme A (acetyl-CoA) production and gluconeogenesis.
27 ferentiation in a manner dependent on acetyl coenzyme A (acetyl-CoA) production by the enzyme ATP-cit
28                        The metabolite acetyl-coenzyme A (acetyl-CoA) serves as an essential element f
29 esis by suppressing the expression of acetyl coenzyme A (acetyl-CoA) synthetase (Acss), leading to de
30 s cycle, glyoxylate is condensed with acetyl coenzyme A (acetyl-CoA) to give malate, which undergoes
31 te lyase (ACLY) synthesizes cytosolic acetyl coenzyme A (acetyl-CoA), a fundamental cellular building
32 d is sensitive to the availability of acetyl coenzyme A (acetyl-CoA), we investigated a role for meta
33  demonstrate that A-485 competes with acetyl coenzyme A (acetyl-CoA).
34 e, enabling biosynthesis of cytosolic acetyl coenzyme A (acetyl-CoA, the two-carbon isoprenoid precur
35 e oxidation to fuel the production of acetyl coenzyme A, acetylation of histones and induction of gen
36 n architecturally distinct subfamily of acyl coenzyme A (acyl-CoA) dehydrogenase (ACAD) enzymes that
37 tion process is the recognition of free acyl coenzyme A (acyl-CoA) from the lipid bilayer.
38 the transport of cytoplasmic long chain acyl-coenzyme A (acyl-CoA) into the mitochondrial matrix, whi
39 tion of enzymes regulating long-chain acetyl-coenzyme A (Acyl-CoA) metabolism.
40                         The AMP-forming acyl coenzyme A (acyl-CoA) synthetases are a large class of e
41  activity of the long-chain cytoplasmic acyl coenzyme A (acyl-CoA) thioesterase 7 (ACOT7) to regulate
42 nd di-, poly-, and persulfide derivatives of coenzyme A, although polysulfide itself is also efficien
43 PqsBC catalyzes the condensation of octanoyl-coenzyme A and 2-aminobenzoylacetate (2-ABA) to form the
44  best inhibitors are competitive with acetyl coenzyme A and an X-ray cocrystal structure reveals that
45 -acetyltransferase (gene: Nat8l) from acetyl-coenzyme A and aspartate.
46 amide synthase that uses C16 fatty acid acyl-coenzyme A and dihydroxy LCB substrates but increased ac
47 e enzyme phosphotransacylase (PTAC) recycles Coenzyme A and generates an acyl phosphate that can serv
48 ation of N-acetylglutamate (NAG) from acetyl coenzyme A and glutamate.
49 irement for growth and specifically inhibits coenzyme A and isoleucine biosynthesis.
50 he downstream metabolites, including malonyl-coenzyme A and palmitic acid, completely restored the in
51 ze the hydrolysis of thioester bonds between coenzyme A and phenylacetyl-CoA.
52      Upon incubation of the enzyme with acyl-coenzyme A and reduced nicotinamide adenine dinucleotide
53  to depletion of the energy substrate acetyl coenzyme A and the antioxidant glutathione.
54 ynthases that use very-long-chain fatty acyl-coenzyme A and trihydroxy LCB substrates.
55  in vitro assay requiring only isolated LDs, Coenzyme A, and ATP to drive lipid synthesis.
56 imidine, isoprenoid, methionine, riboflavin, coenzyme A, and folate, as well as other biosynthetic pa
57 th 3,5-dihydroxybenzoic acid, ATP, malonate, coenzyme A, and the malonyl-CoA ligase MatB, venemycin p
58 anine and pantoic acid moieties required for coenzyme A are annotated.
59 s the polymerization of 3-(R)-hydroxybutyryl-coenzyme A as a means of carbon storage in many bacteria
60 cyltransferase that uses preferentially 16:0-coenzyme A as an acyl donor.
61 ounds known to be metabolized by the benzoyl coenzyme A (benzoyl-CoA) pathway.
62 eracting partner, Golgi adaptor protein acyl-coenzyme A binding domain containing protein 3 (ACBD3).
63 uncover that the Golgi resident protein acyl-coenzyme A binding domain-containing 3 (ACBD3) serves as
64 emperature as the different variants of acyl-coenzyme A binding protein have similar m-values when th
65 enzyme kinetics, suggesting decreased acetyl coenzyme A binding.
66 re, we identify the PO membrane protein acyl-coenzyme A-binding domain protein 5 (ACBD5) as a binding
67    Low-molecular mass (10 kD) cytosolic acyl-coenzyme A-binding protein (ACBP) has a substantial infl
68                       Here we show that acyl-coenzyme A-binding protein (ACBP) potently facilitates v
69    SAR-related proteins THIOREDOXIN h3, ACYL-COENZYME A-BINDING PROTEIN6, and PATHOGENESIS-RELATED1 w
70           This is the second inborn error of coenzyme A biosynthesis to be implicated in NBIA.
71 it was uncovered that PZA inhibits bacterial Coenzyme A biosynthesis.
72 mulates the conversion of pyruvate to acetyl-coenzyme A by the pyruvate dehydrogenase complex.
73 ctivated protein kinase activation of acetyl-coenzyme A carboxylase (ACC) and increased lipid content
74 s phosphorylation and inactivation of acetyl coenzyme A carboxylase (ACC).
75 ar gene (ACC2) that targets homomeric acetyl-coenzyme A carboxylase (ACCase) to plastids.
76           T cell-specific deletion of acetyl coenzyme A carboxylase 1 (ACC1), an enzyme that catalyze
77 ort into mitochondria via deletion of acetyl coenzyme A carboxylase 2 (ACC2) does not cause cardiomyo
78 tural environments, where heteromeric acetyl-coenzyme A carboxylase encoded in part by the chloroplas
79 d nuclear gene that targets homomeric acetyl-coenzyme A carboxylase to plastids, where the multidomai
80 l regulatory element-binding protein, acetyl coenzyme A carboxylase, and fatty acid synthase.
81  in ACC2, encoding a plastid-targeted acetyl-coenzyme A carboxylase, cause hypersensitivity to specti
82 DI-010976, an allosteric inhibitor of acetyl-coenzyme A carboxylases (ACC) ACC1 and ACC2, reduces hep
83 the post-translational biotinylation of acyl coenzyme A carboxylases.
84     3) Direct acetyl transfer between LD and coenzyme A catalyzed by E2pCD was observed with a rate c
85           We have found previously that acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibition
86 physical interaction of the major SOAT, acyl-coenzyme A:cholesterol acyltransferase (ACAT)-related en
87 ress the cholesterol-esterifying enzyme acyl-coenzyme A:cholesterol acyltransferase (ACAT1), but not
88  sterol O-acyltransferase 1 (also named acyl-coenzyme A:cholesterol acyltransferase, ACAT1) transfers
89 -acyltransferase (MBOAT) enzyme family, acyl-coenzyme A:cholesterol acyltransferases (ACATs) catalyse
90               Acetate, a precursor of acetyl coenzyme A (CoA) (a product of fatty acid beta-oxidation
91                                              Coenzyme A (CoA) and acetyl-coenzyme A (acetyl-CoA) are
92 abundance of the low molecular weight thiols coenzyme A (CoA) and glutathione in S47 cells.
93 ched-chain amino acid metabolism, isovaleryl-Coenzyme A (CoA) and isobutyryl-CoA, with three molecule
94  N-acyltransferase reaction using fatty acyl-coenzyme A (CoA) and long-chain base (LCB) substrates to
95              Cofactors such as NAD, AMP, and Coenzyme A (CoA) are essential for a diverse set of reac
96  (PanK) is a regulatory enzyme that controls coenzyme A (CoA) biosynthesis.
97 olution crystal structure of AF-Est2 reveals Coenzyme A (CoA) bound in the vicinity of the active sit
98  discussed in the context of the peroxisomal coenzyme A (CoA) budget.
99 roduce mm flux through the key fluoromalonyl coenzyme A (CoA) building block, thereby offering the po
100          Pharmaceutical inhibition of acetyl-coenzyme A (CoA) carboxylase (ACC), a key fatty acid bio
101 (OG) is a small molecule inhibitor of acetyl coenzyme A (CoA) carboxylase (ACC), the enzyme that cont
102  kinase (AMPK) levels, and diminished acetyl coenzyme A (CoA) carboxylase phosphorylation than in the
103       Two genes, Psyr_2474, encoding an acyl-coenzyme A (CoA) dehydrogenase, and Psyr_4843, encoding
104                                          Its coenzyme A (CoA) derivative, itaconyl-CoA, inhibits B(12
105  The Arabidopsis (Arabidopsis thaliana) acyl-coenzyme A (CoA) desaturase-like (ADS) gene family conta
106 ly conserved ER protein FIT2 as a fatty acyl-coenzyme A (CoA) diphosphatase that hydrolyzes fatty acy
107  catalyzes the reduction of hydroxycinnamoyl-coenzyme A (CoA) esters using NADPH to produce hydroxyci
108  metabolic machinery for the biosynthesis of Coenzyme A (CoA) from exogenous pantothenic acid (Vitami
109 directed metabolic fluxes to generate acetyl-Coenzyme A (CoA) from glucose resulting in augmented his
110 nome of MLL-rearranged AML by linking acetyl-coenzyme A (CoA) homeostasis to Bromodomain and Extra-Te
111 eport the identification of a putative enoyl-coenzyme A (CoA) hydratase/isomerase that is required fo
112          While homologous to mammalian enoyl-coenzyme A (CoA) hydratases, EchA6 is non-catalytic yet
113 ty of SPT, allowing utilization of myristoyl-coenzyme A (CoA) in addition to its canonical substrate
114 brida) flowers have the precursor 4-coumaryl coenzyme A (CoA) in common.
115 tion of HMP is also compromised in vivo when coenzyme A (CoA) levels are reduced.
116 zyme DmdB, a methylmercaptopropionate (MMPA)-coenzyme A (CoA) ligase, catalyzes the second step in th
117    DmdB, a 3-methylmercaptopropionate (MMPA)-coenzyme A (CoA) ligase, undergoes two sequential confor
118  a BL-04 gene encoding long-chain fatty acid coenzyme A (CoA) ligase.
119 o enzymes, Ptr4CL3 and Ptr4CL5, catalyze the coenzyme A (CoA) ligation of 4-coumaric acid to 4-coumar
120                                              Coenzyme A (CoA) mediates thiol-based acyl-group transfe
121 ation of the meta-hydroxyl group of caffeoyl-coenzyme A (CoA) on the pathway to monolignols, with the
122 ity were correlated with changes in the acyl-coenzyme A (CoA) pool in developing seeds of transgenic
123 cate that YacG is frequently associated with coenzyme A (CoA) production enzymes, linking the protein
124  levels of intermediate and anaplerotic acyl-coenzyme A (CoA) species incorporated into the Krebs cyc
125 tauri extraplastidial lipids, while the 16:4-coenzyme A (CoA) species was not detected.
126 carbon-carbon bond forming step between acyl coenzyme A (CoA) substrates offer a versatile route for
127 aloferax volcanii 3-hydroxy-3-methylglutaryl coenzyme A (CoA) synthase (EC 2.3.310).
128 essive missense mutations in COASY, encoding coenzyme A (CoA) synthase in one NBIA-affected subject.
129 rase superfamily member 2 (Them2) is an acyl-coenzyme A (CoA) thioesterase that catalyzes the hydroly
130 tochondrion-associated long-chain fatty acyl coenzyme A (CoA) thioesterase that is highly expressed i
131 t transfers 4'-phosphopantetheine (Ppt) from coenzyme A (CoA) to diverse acyl carrier proteins.
132  the ATP-dependent conversion of citrate and coenzyme A (CoA) to oxaloacetate and acetyl-CoA(1-5).
133                   The enzymes YfdW, a formyl coenzyme A (CoA) transferase, and YfdU, an oxalyl-CoA de
134 lysophosphatidylethanolamine (LPE) with acyl-coenzyme A (CoA), designated LYSOPHOSPHATIDYLETHANOLAMIN
135                                       Acetyl coenzyme A (CoA), malonyl-CoA, adenosine triphosphate (A
136 fatty acid (LCFA) uptake and activation with coenzyme A (CoA), mediating the fate of LCFA.
137 ate generated during synthesis of fatty acyl-coenzyme A (CoA), the reaction catalyzed by an enzyme in
138 gand binding on the energy landscape of acyl-coenzyme A (CoA)-binding protein (ACBP).
139 ing the final and committed step in the acyl-coenzyme A (CoA)-dependent biosynthesis of triacylglycer
140 metabolites into 4-methyl-pentanol (4MP) via coenzyme A (CoA)-dependent chemistry were taken from nin
141 n complex with Acetyl-Coenzyme A (Ac-CoA) or Coenzyme A (CoA).
142 ynthesis of the universal essential cofactor Coenzyme A (CoA).
143 s FALDH) prior to activation via coupling to coenzyme A (CoA).
144 anine, spermine, dihydrouracil, and acryloyl-coenzyme A (CoA).
145 ocess that requires the generation of acetyl-coenzyme A (CoA).
146 LMW) thiols, including glutathione (GSH) and coenzyme A (CoA).
147 on via the reductive conversion to propionyl-coenzyme A (CoA).
148 ffusion of the much larger cofactors NAD and coenzyme A (CoA).
149 ative abundance of the gene encoding butyryl-coenzyme A (CoA):acetate-CoA-transferase, a major enzyme
150 eneration (PKAN) and result in low levels of coenzyme-A (CoA) in the CNS due to impaired production o
151 gluconeogenesis due to sequestration of free coenzyme A (CoASH).
152 ecreased the expression of medium-chain acyl coenzyme A dehydrogenase (MCAD) and short-chain acyl coe
153  A dehydrogenase (MCAD) and short-chain acyl coenzyme A dehydrogenase (SCAD), involved in the regulat
154 h (enoyl-coenzyme A, hydratase/3-hydroxyacyl coenzyme A dehydrogenase)], and a marker of proximal tub
155 mical analyses showed lower beta-hydroxyacyl coenzyme-A dehydrogenase activity and higher lactate deh
156  methionine, which MddA detoxifies by acetyl coenzyme A-dependent acetylation.
157 rrier protein) synthase (ACPS) catalyzes the coenzyme A-dependent activation of apo-ACPP to generate
158 wo separable mechanisms: dampening of acetyl-coenzyme A-dependent carbon metabolism through histone h
159  unable to convert free fatty acids to their coenzyme A derivatives, accumulates free fatty acids dur
160 rom palmitic acid (PA) catalyzed by stearoyl-coenzyme A desaturase (SCD) activity.
161                          Changes in stearoyl-coenzyme A desaturase (SCD) expression and activity were
162 es, we conducted a mouse trial of a stearoyl-coenzyme A desaturase (SCD) inhibitor ("5b") that preven
163 e cellular lipid reprogramming upon stearoyl-coenzyme A desaturase 1 (SCD1) inhibition.
164 0 (P = 1.6 x 10(-8)) as a marker of stearoyl coenzyme A desaturase 1 activity, and the ratio of 20:3n
165 abolism genes (fatty acid synthase, stearoyl-coenzyme A desaturase 1, and perilipin 2) was drasticall
166 This review provides an overview of stearoyl-coenzyme A desaturase-1 (SCD1) as a novel therapeutic ta
167                   Aramchol, an oral stearoyl-coenzyme-A-desaturase-1 inhibitor, has been shown to red
168 ate (P-HPD, an isomer of AI-2-phosphate) and coenzyme A, determine the crystal structure of an LsrF c
169 of increased or decreased expression of ACYL-COENZYME A:DIACYLGLYCEROL ACYLTRANSFERASE1 (DGAT1) or PH
170 one (line CL37) or together with castor acyl:coenzyme A:diacylglycerol acyltransferase2 reduced HFA a
171 ex (PDHc), which converts pyruvate to acetyl coenzyme A, enables E. coli to resist these antimicrobia
172 uided mutational analyses suggests that acyl-coenzyme A enters the active site through the cytosolic
173  level on the non-heme diiron enzyme benzoyl coenzyme A epoxidase, BoxB.
174 es high carbon flux through the ethylmalonyl coenzyme A (ethylmalonyl-CoA) pathway (EMC pathway).
175 ond within acetyl-CoA, producing acetate and coenzyme A for a range of cellular processes.
176 lism; this limits the availability of acetyl coenzyme A for histone acetylation at genes encoding inf
177  group of N(10)-formyl-THF to produce formyl-coenzyme A (formyl-CoA) as a central reaction intermedia
178   The biosynthesis of the major acyl carrier Coenzyme A from pantothenic acid (PA) is critical for su
179 boxylic acid (TCA) cycle by producing acetyl coenzyme A from pyruvate.
180 interestingly, we also identified endogenous coenzyme A glutathione disulfide (CoA-S-S-G) in tissue f
181 tein E (ApoE) and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR)) has been linked t
182 ts under regular 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitor (statin) treatm
183   Until recently, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) have
184 e shown that the 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors known as stati
185                      Hydroxy-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors or statins are
186       Statins, or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, have anti-inf
187 ition particle or 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase.
188   The mevalonate [3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase] pathway synthesizes lipi
189 y acid-binding protein 1), and Ehhadh (enoyl-coenzyme A, hydratase/3-hydroxyacyl coenzyme A dehydroge
190 razinamide (PZA), interrupts biosynthesis of coenzyme A in Mycobacterium tuberculosis by binding to a
191         We describe, for example, a putative coenzyme-A-induced-fit substrate binding mechanism media
192 degradation through hydration of the dienoyl-coenzyme A intermediate as observed in Geobacter metalli
193       We further demonstrated that palmitoyl coenzyme A is a ligand for the PvrA, enhancing the bindi
194                                              Coenzyme A is an essential metabolite known for its cent
195                                    In cells, Coenzyme A is synthesized de novo in five enzymatic step
196            Downregulation of 4-coumaric acid:coenzyme A ligase (4CL) can reduce lignin content in a n
197 ciated domain and coenriches with fatty acyl-coenzyme A ligase Faa1 at LD bud sites.
198 o and activated the promoters of 4-coumarate:coenzyme A ligase genes (Os4CL3 and Os4CL5) resulting in
199  that the gene encoding a specific cinnamate coenzyme A ligase likely obtained its new function follo
200 n Escherichia coli, synthesis of the malonyl coenzyme A (malonyl-CoA) required for membrane lipid syn
201 nolignols under the catalysis of p-coumaroyl-coenzyme A monolignol transferase (PMT).
202          The rice (Oryza sativa) p-COUMAROYL-Coenzyme A MONOLIGNOL TRANSFERASE gene was introduced in
203            Plants expressing the p-COUMAROYL-Coenzyme A MONOLIGNOL TRANSFERASE transgene can therefor
204 eficiency of the mitochondrial methylmalonyl-coenzyme A mutase (MMUT).
205 tion, we cloned and characterized a caffeoyl-coenzyme A O-methyltransferase (PhCCoAOMT1) from the pet
206 ed protein (Adrp), whereas it augmented acyl-coenzyme A oxidase 1 (Acox-1), proliferator-activated re
207 lytic transport involving sliders (including coenzyme A) picking up, transporting and selectively del
208 s and in vivo rescue potential of the acetyl-Coenzyme A precursor S-acetyl-4'-phosphopantetheine as a
209      One therapeutic strategy is to generate Coenzyme A precursors downstream of the defective step i
210 ctivity, contributed significantly to acetyl-coenzyme A production.
211 spectrometric sequencing: a hydroxycinnamoyl-Coenzyme A:quinate hydroxycinnamoyl transferase (HQT) wa
212 ne expressing castor FA hydroxylase and acyl-Coenzyme A:RcDGAT2 in its seeds.
213                                    Cinnamoyl-coenzyme A reductase (CCR) catalyzes the reduction of hy
214 olesterol, in the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) activity, and in the in vit
215                   3-hydroxy-3-methylglutaryl-Coenzyme A reductase (HMGCR) encodes the rate-limiting e
216 ombination with a 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) inhibitor (statin), will re
217  in Npc1a weakens the ability of ectopic HMG Coenzyme A reductase (Hmgcr) to induce germ cell migrati
218  the formation of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), a main regulator of choles
219 thway upstream of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the target of statins.
220 ubiquitination of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), which catalyzes a rate-lim
221 particle (SRP) or 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR).
222 tic inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR).
223 synthesis called 3-hydroxy-3-methyl-glutaryl coenzyme A reductase (HMGCR).
224 ncoding PCSK9 and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR; the target of statins) as i
225 interfering with 3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMGR) activity, a key player in is
226 tylase (HDAC) and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) by having a hydroxamate grou
227        The enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) has a key regulatory role in
228     Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins) can modulate inflammatory
229     Inhibitors of 3-hydroxy-3-methylglutaryl-Coenzyme A reductase and isoprenylation attenuated, wher
230                       Hydroxymethyl glutaryl-coenzyme A reductase degradation protein 1 (Hrd1) is an
231 AHA/ACC) changed 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor (statin) eligibility crit
232  indications for 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor (statin) therapy than mid
233 es of the influence of hydroxymethylglutaryl-coenzyme A reductase inhibitors (also known as statins)
234       Purpose The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) have activity
235                   3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been vari
236 ering properties, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have broad ant
237         Statins, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors have been shown to impro
238          Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are an important group
239          Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors), commonly prescribed in
240 ted with elevated 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA levels and anti-Src-Tyr416 imm
241 inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway to protect against infectio
242 osynthetic enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase results from its sterol-induced bin
243 non-initiation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase therapy in patients with cirrhosis
244 roxylase) and ccr1g (deficient for cinnamoyl-coenzyme A reductase) lines, albeit to a lower extent.
245  protein 2, human 3-hydroxy-3-methylglutaryl-coenzyme A reductase, and human low-density lipoprotein
246 e-limiting enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase, and increased plasma membrane chol
247  by inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, are among the most widely prescrib
248 family B member 1, peroxisomal trans-2-enoyl-coenzyme A reductase, phospholipase A2 receptor, protein
249 emia, inhibit the 3-hydroxy-3-methylglutaryl-coenzyme A reductase, the rate-limiting enzyme of de nov
250 ically inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase, which is a rate-limiting enzyme fo
251 ive inhibitor of 3-hydroxy-2-methyl-glutaryl coenzyme A reductase.
252 rget of pitavastatin, hydroxymethylglutarate coenzyme-A reductase (HMGCR), was found to be over-expre
253 tins, or HMG CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors, are drugs with multipl
254 ECR encoding the mitochondrial trans-2-enoyl-coenzyme A-reductase involved in human mtFAS.
255              Here, we reintroduced CINNAMOYL-COENZYME A REDUCTASE1 (CCR1) expression specifically in
256 he genes encoding 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE1 (HMGR1) and MAKIBISHI1, the rate-l
257 1) and CER3 catalyzes the conversion of acyl-Coenzyme A's to alkanes with strict substrate specificit
258 ctly dependent on metabolites such as acetyl-coenzyme A, S-adenosylmethionine, and NAD+, among others
259 olignol biosynthetic enzyme hydroxycinnamoyl coenzyme A:shikimate hydroxycinnamoyl transferase (HCT)
260                           Mitochondrial acyl-coenzyme A species are emerging as important sources of
261                        We show that succinyl-coenzyme A (succinyl-CoA) binds to KAT2A.
262                                   The acetyl coenzyme A synthase (ACS) enzyme plays a central role in
263       Here, we identified a novel biomarker, coenzyme A synthase (COASY), whose mRNA expression was c
264 onfirmed the role of a hydroxymethylglutaryl-coenzyme A synthase cassette, three flavin-dependent tai
265 ein-based model for the NiP center of acetyl coenzyme A synthase using a nickel-substituted azurin pr
266 nic genes such as 3-hydroxy-3-methylglutaryl-coenzyme A synthase, fatty acid synthase, and stearoyl-C
267 6K1 in insulin-stimulated adipocytes-namely, coenzyme A synthase, lipocalin 2, and cortactin.
268               The 3-hydroxy-3-methylglutaryl coenzyme A synthases (HCSs) are responsible for beta-alk
269 this study is to explore parasite fatty acyl-coenzyme A synthetase (ACS) as a novel drug target.
270 lysine acylation in metabolism is the acetyl-coenzyme A synthetase (Acs) enzyme.
271 or the acetylation of the AMP-forming acetyl coenzyme A synthetase (SacAcsA, SACE_2375).
272                                     Succinyl Coenzyme A synthetase (SCS) is a key mitochondrial enzym
273         Here, we show that loss of the VLCFA-coenzyme A synthetase Fat1, which is essential for VLCFA
274   Although many Archaea have AMP-Acs (acetyl-coenzyme A synthetase) and ADP-Acs, the extant methanoge
275                                         Acyl coenzyme A synthetase-1 (ACSL1) facilitates long-chain f
276 ctroscopy, the cutin mutants long-chain acyl-coenzyme A synthetase2 (lacs2), permeable cuticle1 (pec1
277 enin polyketide biosynthetic metabolon (ACYL COENZYME A SYNTHETASE5, POLYKETIDE SYNTHASE A [PKSA], PK
278 is activation is mediated by long-chain acyl-coenzyme A synthetases (LACSs), which are encoded by a f
279 knockout plants have a higher level, of acyl-coenzyme A than the wild type.
280 cycle for the generation of cytosolic acetyl-coenzyme A that can be used for fatty acid and cholester
281  need to be converted to their corresponding coenzyme A thioesters to become metabolically available.
282                            It catalyzes acyl-coenzyme A thioesters to synthesize naringenin chalcone
283 talyze the sequential esterification of acyl-coenzyme A thioesters to the R4, R3, R3', and R2 positio
284 aine via the activated benzoyl- or cinnamoyl-Coenzyme A thioesters, respectively.
285                  Of the two major 3-ketoacyl coenzyme A thiolases, KAT2 plays the primary role in BA
286 lyse the transfer of an acyl group from acyl-coenzyme A to cholesterol to generate cholesteryl ester,
287 LDHA maintains high concentrations of acetyl-coenzyme A to enhance histone acetylation and transcript
288 n enzyme that catalyzes conversion of acetyl coenzyme A to malonyl coenzyme A, a carbon donor for lon
289  the transfer of an acetyl group from acetyl coenzyme A to polyamines such as spermidine and spermine
290 hydrolyzes phosphatidylcholine and also acyl-coenzyme A to release fatty acids.
291 rix where glycine is condensed with succinyl coenzyme A to yield delta-aminolevulinic acid.
292 ons suggested that SvBAHD05 is a p-coumaroyl coenzyme A transferase (PAT) mainly involved in the addi
293                           Inspired by acetyl-coenzyme A transporting and delivering acetyl groups in
294 ith the high carbon efficiency drive, acetyl-coenzyme A was entirely produced using the carbon-effici
295 the synthesis of nicotinate, NAD+, NADP+ and coenzyme A were detected among the essential vitamins an
296 for their mission: E1 and E2 generate acetyl-coenzyme A, whereas the FAD/NAD(+)-dependent E3 performs
297 onverted to the central intermediate benzoyl-coenzyme A, which is enzymatically reduced to cyclohexa-
298  used cysteine to synthesize glutathione and coenzyme A, which, together, down-regulated ferroptosis.
299 ich decarboxylates pyruvate and forms acetyl-coenzyme A with concomitant reduction of low-potential f
300 he transfer of an acetyl group from P-HPD to coenzyme A yielding dihydroxyacetone phosphate and acety

 
Page Top